Martin John Corbett is a notable inventor based in Mt. Holly, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that enhance animal growth and health. With a total of 5 patents to his name, Corbett's work has had a meaningful impact on agricultural practices.

Latest Patents

Corbett's latest patents include innovative solutions such as biologically active porcine somatotropin polypeptides. This invention provides an isolated polypeptide corresponding to the epitope of porcine somatotropin, along with methods for enhancing animal growth through its administration. Another significant patent involves the use of bovine serum and bovine IgG as preventives and therapeutics for bovine health. Specifically, Immunoglobulin G-2 (IgG2), such as bovine IgG2, can enhance the functional status of neutrophils in host animals, aiding in their defense against bacterial infections.

Career Highlights

Corbett has spent a considerable part of his career at the American Cyanamid Company, where he has been able to apply his expertise in biotechnology. His work has not only advanced scientific understanding but has also contributed to practical applications in animal husbandry.

Collaborations

Throughout his career, Corbett has collaborated with esteemed colleagues such as Hong-Ming Shieh and Cecil Mark Eppler. These partnerships have fostered innovation and have led to the successful development of various biotechnological advancements.

Conclusion

Martin John Corbett's contributions to biotechnology and animal health are noteworthy. His innovative patents and collaborations have significantly influenced the field, showcasing the importance of scientific research in improving agricultural practices.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com